BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35904312)

  • 1. Impact of outcome definitions on cardiovascular risk prediction in a contemporary primary prevention population.
    Sud M; Chu A; Austin PC; Naimark DM; Thanassoulis G; Wijeysundera HC; Ko DT
    Eur Heart J Qual Care Clin Outcomes; 2023 Jun; 9(4):427-434. PubMed ID: 35904312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data.
    Lindh M; Banefelt J; Fox KM; Hallberg S; Tai MH; Eriksson M; Villa G; Svensson MK; Qian Y
    Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):225-232. PubMed ID: 30649251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
    Rosenblit PD
    Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic Cardiovascular Disease or Heart Failure: First Cardiovascular Event in Adults With Prediabetes and Diabetes.
    Sinha A; Ning H; Cameron N; Bancks M; Carnethon MR; Allen NB; Wilkins JT; Lloyd-Jones DM; Khan SS
    J Card Fail; 2023 Mar; 29(3):246-254. PubMed ID: 36343785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
    Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
    Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
    Kim G; Youn HJ; Choi YS; Jung HO; Chung WS; Kim CM
    Clin Interv Aging; 2015; 10():1111-9. PubMed ID: 26185430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.
    Khawaja T; Linge J; Leinhard OD; Al-Kindi SG; Rajagopalan S; Khera A; de Lemos JA; Joshi P; Neeland IJ
    Prog Cardiovasc Dis; 2023; 78():67-73. PubMed ID: 36931545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Mitochondrial DNA Copy Number With Cardiovascular Disease.
    Ashar FN; Zhang Y; Longchamps RJ; Lane J; Moes A; Grove ML; Mychaleckyj JC; Taylor KD; Coresh J; Rotter JI; Boerwinkle E; Pankratz N; Guallar E; Arking DE
    JAMA Cardiol; 2017 Nov; 2(11):1247-1255. PubMed ID: 29049454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Hageman SHJ; McKay AJ; Ueda P; Gunn LH; Jernberg T; Hagström E; Bhatt DL; Steg PG; Läll K; Mägi R; Gynnild MN; Ellekjær H; Saltvedt I; Tuñón J; Mahíllo I; Aceña Á; Kaminski K; Chlabicz M; Sawicka E; Tillman T; McEvoy JW; Di Angelantonio E; Graham I; De Bacquer D; Ray KK; Dorresteijn JAN; Visseren FLJ
    Eur Heart J; 2022 May; 43(18):1715-1727. PubMed ID: 35165703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between 5-year change in cardiovascular risk and the incidence of atherosclerotic cardiovascular diseases: a multi-cohort study.
    Yi J; Wang L; Guo X; Ren X
    J Transl Med; 2023 Sep; 21(1):589. PubMed ID: 37660053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context.
    Toth PP; Danese M; Villa G; Qian Y; Beaubrun A; Lira A; Jansen JP
    J Med Econ; 2017 Jun; 20(6):555-564. PubMed ID: 28097904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort.
    Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L
    BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
    Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
    Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies.
    Lawler PR; Kotrri G; Koh M; Goodman SG; Farkouh ME; Lee DS; Austin PC; Udell JA; Ko DT
    Eur Heart J; 2020 Jan; 41(1):86-94. PubMed ID: 31733058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention.
    Hwang IC; Kim CH; Kim JY; Choi HM; Yoon YE; Cho GY
    Hypertension; 2023 Aug; 80(8):1697-1706. PubMed ID: 37470768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study.
    Kim H; Kim S; Han S; Rane PP; Fox KM; Qian Y; Suh HS
    BMC Public Health; 2019 Aug; 19(1):1112. PubMed ID: 31412823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population.
    Park S; Kim YG; Ann SH; Cho YR; Kim SJ; Han S; Park GM
    Epidemiol Health; 2023; 45():e2023052. PubMed ID: 37189276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.
    Yano Y; O'Donnell CJ; Kuller L; Kavousi M; Erbel R; Ning H; D'Agostino R; Newman AB; Nasir K; Hofman A; Lehmann N; Dhana K; Blankstein R; Hoffmann U; Möhlenkamp S; Massaro JM; Mahabadi AA; Lima JAC; Ikram MA; Jöckel KH; Franco OH; Liu K; Lloyd-Jones D; Greenland P
    JAMA Cardiol; 2017 Sep; 2(9):986-994. PubMed ID: 28746709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease (CVD) outcomes and associated risk factors in a medicare population without prior CVD history: an analysis using statistical and machine learning algorithms.
    Lip GYH; Genaidy A; Estes C
    Intern Emerg Med; 2023 Aug; 18(5):1373-1383. PubMed ID: 37296355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Family History Increases the Risk of Disease Recurrence After a First Myocardial Infarction.
    Wahrenberg A; Kuja-Halkola R; Magnusson PKE; Häbel H; Warnqvist A; Hambraeus K; Jernberg T; Svensson P
    J Am Heart Assoc; 2021 Dec; 10(23):e022264. PubMed ID: 34845931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.